Potential Immune Microenvironment Biomarkers in SCLC: J-TAIL-2 Observational Study
CD8+ TIL density is a potential biomarker of clinical benefit in ES-SCLC and may facilitate patient selection for atezolizumab combination therapy.
Authors
- Kadoaki Ohashi (ORCID: https://orcid.org/0000-0002-5180-3933)
- Akihiko Gemma (ORCID: https://orcid.org/0000-0003-0762-2737)
- Eisaku Miyauchi (ORCID: https://orcid.org/0000-0002-6837-6392)
- Junichi Shimizu (ORCID: https://orcid.org/0000-0001-9078-0968)
- Toshihiro Misumi (ORCID: https://orcid.org/0000-0001-8339-2895)
- Yasushi Goto (ORCID: https://orcid.org/0000-0002-7437-5054)
- Hiroshige Yoshioka (ORCID: https://orcid.org/0000-0001-7724-0481)
- Atsushi Osoegawa (ORCID: https://orcid.org/0000-0002-8327-3631)
- Hiromi Ashimura
- Yasushi Yatabe (ORCID: https://orcid.org/0000-0003-1788-559X)
- Jumpei Kashima (ORCID: https://orcid.org/0000-0002-5225-9319)
- Masayuki Shirasawa (ORCID: https://orcid.org/0000-0001-9948-3441)
- Yuki Kobayashi (ORCID: https://orcid.org/0000-0002-8855-9858)
- Eiki Kikuchi (ORCID: https://orcid.org/0000-0003-4098-6321)
- Makoto Nishio (ORCID: https://orcid.org/0000-0003-4969-4165)
- Tatsuya Yoshida (ORCID: https://orcid.org/0000-0003-4896-5824)
- Masahide Oki (ORCID: https://orcid.org/0000-0001-6302-4534)
- Hideharu Kimura
- Ichiro Yoshino (ORCID: https://orcid.org/0009-0003-4007-9606)
- Misa Tanaka
Institutions
- Kansai Medical University (JP)
- Oita University (JP)
- Hokkaido University (JP)
- Tohoku University Hospital (JP)
- Chiba University Hospital (JP)
- Okayama University Hospital (JP)
- Kanazawa University Hospital (JP)
- Aichi Cancer Center (JP)
- Dokkyo Medical University Saitama Medical Center (JP)
- National Cancer Center Hospital East (JP)
- Nagoya Medical Center (JP)
- Social Insurance Saitama Chuo Hospital (JP)
- Japanese Foundation For Cancer Research (JP)
- International University of Health and Welfare (JP)
- Nippon Medical School (JP)
Publication Details
- Journal
- JTO Clinical and Research Reports
- Published
- 2025-10-30
- DOI
- https://doi.org/10.1016/j.jtocrr.2025.100926
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chugai Pharmaceutical